MedPath

Inclusive Invasive Physiological Assessment in Angina Syndromes Registry

Completed
Conditions
Coronary Artery Disease
Microvascular Coronary Artery Disease
Interventions
Diagnostic Test: Resting distal coronary to aortic pressure ratio, Fractional flow reserve, Coronary Flow Reserve, Microvascular resistance
Registration Number
NCT04485234
Lead Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Brief Summary

This study evaluates the prognostic value and potential therapeutic impact of combined pressure and flow measurements in the evaluation of epicardial coronary stenosis and microvascular function.

Detailed Description

ILIAS registry is a global effort to gather lesion-level data on the diagnostic and prognostic value of combined coronary pressure and flow measurements in clinical practice. Data is gathered from 7 nations (The Netherlands, Korea, Japan, Spain, Italy, Denmark, USA), using either coronary Doppler velocity measurements or coronary thermodilution measurements to obtain invasive coronary flow assessment. Patient treatment was governed by the local clinical practice guidelines at the time of the invasive procedure, but was at the operator's discretion. A standardized data collection sheet was used and all study adopted standardized definition of patient's baseline characteristics, clinical outcomes, and physiologic data. In case of acute coronary syndrome (unstable angina, non-ST-segment elevation myocardial infarction, and ST-segment elevation myocardial infarction), only non-culprit vessel evaluation was used.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2322
Inclusion Criteria
  • underwent combined measurements of coronary pressure and flow for at least 1native coronary artery
Exclusion Criteria
  • hemodynamic instability
  • culprit vessel of acute coronary syndrome

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
All patientsResting distal coronary to aortic pressure ratio, Fractional flow reserve, Coronary Flow Reserve, Microvascular resistanceAll lesions undergo assessment with coronary pressure sensor and either Doppler velocity or coronary thermodilution
Primary Outcome Measures
NameTimeMethod
Major adverse cardiac events10 years

Cumulative incidence of a composite of any death, any myocardial infarction, or any ischemia-driven revascularization

Secondary Outcome Measures
NameTimeMethod
Individual components of MACE and TVF10 years

Cumulative incidence of the individual components of MACE and TVF

Target vessel failure10 years

Cumulative incidence of a composite of cardiac death, target-vessel related myocardial infarction, or target-vessel revascularization

Trial Locations

Locations (12)

Cincinnati University Medical Center

🇺🇸

Cincinnati, Ohio, United States

Catholic University of the Sacred Heart

🇮🇹

Roma, Italy

Gifu Heart Center

🇯🇵

Gifu, Japan

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Amsterdam UMC - location AMC

🇳🇱

Amsterdam, Netherlands

Toda Central General Hospital

🇯🇵

Toda, Japan

Tsuchiura Kyodo General Hospital

🇯🇵

Tsuchiura, Japan

Amphia Hospital

🇳🇱

Breda, Netherlands

Tergooi

🇳🇱

Blaricum, Netherlands

Aarhus University Hospital

🇩🇰

Aarhus, Denmark

Hospital Clinico San Carlos

🇪🇸

Madrid, Spain

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath